Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
31 Cards in this Set
- Front
- Back
Mechanical host defenses
|
Epithelial barriers
Fluid flow |
|
Innate host defenses
|
Defensins, lysozyme, lactoferrin
Phagocytic cells NK cells TLR-responsive cells Complement |
|
Adaptive immune defenses
|
Antibody
Cell-mediated |
|
Neutrophil host defense
|
Extracellular bacteria
Fungi |
|
Macrophage host defense
|
Intracellular bacteria
Fungi |
|
NK cell host defense
|
Viruses
|
|
Complement host defense
|
Extracellular bacteria
|
|
Cell-mediated host defense
|
Intracellular bacteria
Viruses Fungi |
|
Antibody
|
Extracellular bacteria
Viruses Fungi Parasites (IgE) |
|
Physical or mechanical barrier defect - organisms
|
Staph aureus
Streptococci Pseudomonas Aspergillus Candida |
|
Phagocyte defect
|
Staph aureus
Strep pyogenes Haemophilus influenza Klebsiella and E coli Pseudomonas Bacteroides Nocardia Aspergillus Candida |
|
Complement defect
|
Neisseria
Strep pneumo Pseudomonas |
|
T cell defect
|
CMV, HSV, VZV
Listeria, mycobacteria, nocardia Candida, aspergillus, cryptococcus, histoplasma, pneumocystis |
|
B cell defect
|
Enteroviruses
Strep pneumo Haemophilus Neisseria meningitidis Staph aureus Pneumocystis Giardia |
|
Etiology of immune deficiency
|
Congenital
Acquired |
|
Acquired causes of immune deficiency
|
Chemotherapy
Steroids TNF inhibitors HIV, malignancy, or diabetes Transplantation Burns Malnutrition |
|
Cancer chemotherapy - risk factors for infection
|
Severity
Acuity of onset Longer duration |
|
Cancer chemotherapy - immune defect
|
Neutropenia
From drugs, autoimmune destruction, and suppressed bone marrow |
|
Cancer chemotherapy - treatment
|
Empiric antibiotics at onset of fever
Antipseudomonal - ceftazidime, cefepime,carbapenems, piperacillin Vancomycin for MRSA Anaerobic coverage if oropharyngeal or intra-abdominal |
|
Cancer chemotherapy - organisms
|
Staph
Pseudomonas |
|
Solid organ transplant - pre-transplant risk factors
|
Underlying diseases or comorbidities
Organ - highest in lung and liver, next in heart and kidney Previous exposure Age |
|
Solid organ transplant - intra-operative risk factors
|
Duration of surgery
Complications Exposure to blood products |
|
Solid organ transplant - post-transplant risk factors
|
Immunosuppression
Catheters Nosocomial infections |
|
Solid organ transplant - early risk period
|
First month
Defects in mucosal barriers and nosocomial exposure Catheter-associated Pneumonia UTI C difficile colitis |
|
Solid organ transplant - immunosuppressive period
|
1-6 months
T cell defects - DNA viruses, especially CMV Opportunistic fungi TB Toxoplasmosis |
|
Solid organ transplant - late period
|
More than 6 months
Some have persistent T cell deficits |
|
Bone marrow transplant - defects
|
Everything but complement
|
|
Bone marrow transplant - pre-engraftment period
|
Chemotherapy causes neutropenia
Bacteria, candida, aspergillus, and mold infection |
|
Bone marrow transplant - early post-engraftment risk factors
|
Lymphopenia
Splenic dysfunction CVC GVHD |
|
Bone marrow transplant - early post-engraftment period infections
|
CMV - highest risk if recipient is seropositive, donor negative
Respiratory viruses Aspergillus |
|
Bone marrow transplant - late post-engraftment
|
Chronic GVHD
VZV Bacteria |